+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans



In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans



Medical Mycology 43(3): 227-233



To evaluate the therapeutic potential of FX0685, a new triazole antifungal agent, for the treatment of opportunistic fungal infections, particularly systemic candidiasis and aspergillosis, in vitro and in vivo studies were performed using fluconazole (FLC), itraconazole (ITC) and/or amphotericin B (AMB) as reference drugs.

(PDF emailed within 0-6 h: $19.90)

Accession: 004197554

Download citation: RISBibTeXText

PMID: 16010849

DOI: 10.1080/13693780410001731600


Related references

Comparison of D0870, a new triazole antifungal agent, to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assays. Antimicrobial Agents and ChemoTherapy 40(6): 1382-1386, 1996

Combination of fluconazole with non-antifungal agents: a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery. International Journal of Antimicrobial Agents 43(5): 395-402, 2014

Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis. Cellular Physiology and Biochemistry 40(3-4): 727-742, 2016

Potent Antifungal Activity of Pure Compounds from Traditional Chinese Medicine Extracts against Six Oral Candida Species and the Synergy with Fluconazole against Azole-Resistant Candida albicans. Evidence-Based Complementary and Alternative Medicine 2012: 106583-106583, 2012

In vitro and in vivo antifungal activities of the eight steroid saponins from Tribulus terrestris L. with potent activity against fluconazole-resistant fungal pathogens. Biological & Pharmaceutical Bulletin 28(12): 2211-2215, 2005

In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida. Antimicrobial Agents and ChemoTherapy 44(8): 2017-2022, 2000

Selective inhibitory action of fluconazole, an antifungal agent of triazole-derivative, on sterol 14-C demethylation of Candida albicans cells. Japanese Journal of Medical Mycology 27(3): 190-197, 1986

In vivo antifungal activity of CS-758 II Efficacy against experimental oropharyngeal candidiasis in mice caused by fluconazole -resistant Candida albicans. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 253, 2001

In vitro antifungal activity of essential oils extracted from plants against fluconazole-susceptible and -resistant Candida albicans. Current Medical Mycology 3(2): 1-6, 2018

Antifungal activities of D0870 against fluconazole-resistant Candida albicans. Nihon Ishinkin Gakkai Zasshi 40(4): 209-215, 1999

Antifungal activity of Rubus chingii extract combined with fluconazole against fluconazole-resistant Candida albicans. Microbiology and Immunology 60(2): 82-92, 2016

Derivatization of berberine based on its synergistic antifungal activity with fluconazole against fluconazole-resistant Candida albicans. Yao Xue Xue Bao 49(11): 1563-1568, 2016

Antifungal activity of essential oils from Iranian plants against fluconazole-resistant and fluconazole-susceptible Candida albicans. Avicenna Journal of Phytomedicine 6(2): 215-222, 2016

Antifungal pharmacodynamic activity of the investigational echinocardia LY303366 against fluconazole-sensitive and fluconazole-resistant Candida albicans. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36(0): 108, 1996

Antifungal activity of sordarin derivatives against fluconazole-susceptible and -resistant Candida albicans. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 548, 1999